KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Net Cash Flow (2017 - 2025)

Cardlytics (CDLX) has disclosed Net Cash Flow for 9 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Cash Flow rose 460.28% year-over-year to $4.7 million, compared with a TTM value of -$17.1 million through Dec 2025, up 34.42%, and an annual FY2025 reading of -$17.1 million, up 34.42% over the prior year.
  • Net Cash Flow was $4.7 million for Q4 2025 at Cardlytics, up from -$2.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $320.2 million in Q1 2021 and bottomed at -$362.7 million in Q2 2021.
  • Average Net Cash Flow over 5 years is -$12.1 million, with a median of -$4.9 million recorded in 2024.
  • Peak annual rise in Net Cash Flow hit 18889.38% in 2021, while the deepest fall reached 9161.7% in 2021.
  • Year by year, Net Cash Flow stood at -$3.7 million in 2021, then plummeted by 338.92% to -$16.4 million in 2022, then surged by 109.83% to $1.6 million in 2023, then crashed by 181.05% to -$1.3 million in 2024, then soared by 460.28% to $4.7 million in 2025.
  • Business Quant data shows Net Cash Flow for CDLX at $4.7 million in Q4 2025, -$2.7 million in Q3 2025, and -$5.5 million in Q2 2025.